Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1194895

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1194895

Peptide Therapeutics Market Research Report by Technology, API Type, Drug Class, Application, End User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 231 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF & Excel + Online Access - 1 Year (Single User License)
USD 4949
PDF & Excel + Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF & Excel + Online Access - 1 Year (Site License)
USD 6949
PDF & Excel + Online Access - 1 Year (Enterprise User License)
USD 8949

Add to Cart

The Global Peptide Therapeutics Market size was estimated at USD 30.10 billion in 2022 and expected to reach USD 33.40 billion in 2023, projecting growth at a CAGR of 11.03% to reach USD 69.56 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Peptide Therapeutics Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Peptide Therapeutics Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Peptide Therapeutics Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Peptide Therapeutics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Peptide Therapeutics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Technology, the market is studied across Hybrid Phase, Liquid Phase, and Solid Phase.

Based on API Type, the market is studied across CMO and In-house.

Based on Drug Class, the market is studied across Calcitonins, Glucagon & Analogs, Insulins, Luteinizing Hormone-Releasing Hormone, Somatostatins, and Vasopressin.

Based on Application, the market is studied across Anti-infective, Cancer, Cardio Vascular Disease Respiratory, Central Nervous System, Dermatology, Gastrointestinal, Metabolic, and Renal.

Based on End User, the market is studied across Hospitals, Pharmaceutical Industries, and Research Laboratories.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Peptide Therapeutics Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Peptide Therapeutics Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Peptide Therapeutics Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Peptide Therapeutics Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Peptide Therapeutics Market, including AmbioPharm Inc., Amgen Inc., AstraZeneca PLC, Bachem Holding AG, Bristol-Myers Squibb Company, CordenPharma International, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hemmo Pharmaceuticals Pvt Ltd., Ipsen S.A., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., PolyPeptide Group, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zealand Pharma A/S.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Peptide Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peptide Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peptide Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Peptide Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Peptide Therapeutics Market?

6. What is the market share of the leading vendors in the Global Peptide Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Peptide Therapeutics Market?

Product Code: MRR-030EE4851584

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cancer, cardiovascular disorders (CVDs) and metabolic disorder
      • 5.1.1.2. Technology advancement and R & D investment in new peptides
    • 5.1.2. Restraints
      • 5.1.2.1. Poor chemical and physical stability and a short circulating plasma half-life of naturally occurring peptides
    • 5.1.3. Opportunities
      • 5.1.3.1. Presence of strong product pipeline portfolio
      • 5.1.3.2. Adoption of new platforms that develop next-generation protein or peptide therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of stringent safety regulations
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Peptide Therapeutics Market, by Technology

  • 6.1. Introduction
  • 6.2. Hybrid Phase
  • 6.3. Liquid Phase
  • 6.4. Solid Phase

7. Peptide Therapeutics Market, by API Type

  • 7.1. Introduction
  • 7.2. CMO
  • 7.3. In-house

8. Peptide Therapeutics Market, by Drug Class

  • 8.1. Introduction
  • 8.2. Calcitonins
  • 8.3. Glucagon & Analogs
  • 8.4. Insulins
  • 8.5. Luteinizing Hormone-Releasing Hormone
  • 8.6. Somatostatins
  • 8.7. Vasopressin

9. Peptide Therapeutics Market, by Application

  • 9.1. Introduction
  • 9.2. Anti-infective
  • 9.3. Cancer
  • 9.4. Cardio Vascular Disease Respiratory
  • 9.5. Central Nervous System
  • 9.6. Dermatology
  • 9.7. Gastrointestinal
  • 9.8. Metabolic
  • 9.9. Renal

10. Peptide Therapeutics Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Pharmaceutical Industries
  • 10.4. Research Laboratories

11. Americas Peptide Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Peptide Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Peptide Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis, By Key Player
  • 14.3. Market Share Analysis, By Key Player
  • 14.4. Product Portfolio Analysis, By Key Player
  • 14.5. Competitive Scenario
    • 14.5.1. Merger & Acquisition
    • 14.5.2. Agreement, Collaboration, & Partnership
    • 14.5.3. New Product Launch & Enhancement
    • 14.5.4. Investment & Funding
    • 14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. AmbioPharm Inc.
  • 15.2. Amgen Inc.
  • 15.3. AstraZeneca PLC
  • 15.4. Bachem Holding AG
  • 15.5. Bristol-Myers Squibb Company
  • 15.6. CordenPharma International
  • 15.7. Eli Lilly and Company
  • 15.8. F. Hoffmann-La Roche AG
  • 15.9. GlaxoSmithKline PLC
  • 15.10. Hemmo Pharmaceuticals Pvt Ltd.
  • 15.11. Ipsen S.A.
  • 15.12. Merck & Co., Inc.
  • 15.13. Novartis International AG
  • 15.14. Novo Nordisk A/S
  • 15.15. Pfizer Inc.
  • 15.16. PolyPeptide Group
  • 15.17. Sanofi S.A.
  • 15.18. Takeda Pharmaceutical Company Limited
  • 15.19. Teva Pharmaceutical Industries Ltd.
  • 15.20. Zealand Pharma A/S

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing
Product Code: MRR-030EE4851584

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEPTIDE THERAPEUTICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET DYNAMICS
  • FIGURE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
  • FIGURE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, 2018-2030 (USD MILLION)
  • FIGURE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, 2018-2030 (USD MILLION)
  • FIGURE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, 2018-2030 (USD MILLION)
  • FIGURE 18. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2022 VS 2030 (%)
  • FIGURE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY API TYPE, 2030
  • FIGURE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, 2018-2030 (USD MILLION)
  • FIGURE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
  • FIGURE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 24. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG CLASS, 2030
  • FIGURE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, 2018-2030 (USD MILLION)
  • FIGURE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, 2018-2030 (USD MILLION)
  • FIGURE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, 2018-2030 (USD MILLION)
  • FIGURE 29. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, 2018-2030 (USD MILLION)
  • FIGURE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, 2018-2030 (USD MILLION)
  • FIGURE 31. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, 2018-2030 (USD MILLION)
  • FIGURE 32. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 33. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 34. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
  • FIGURE 35. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
  • FIGURE 36. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • FIGURE 37. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, 2018-2030 (USD MILLION)
  • FIGURE 38. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2030 (USD MILLION)
  • FIGURE 39. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
  • FIGURE 40. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2030 (USD MILLION)
  • FIGURE 41. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
  • FIGURE 42. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, 2018-2030 (USD MILLION)
  • FIGURE 43. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 44. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 45. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
  • FIGURE 46. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • FIGURE 47. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, 2018-2030 (USD MILLION)
  • FIGURE 48. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • FIGURE 49. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 50. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 51. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 52. AMERICAS PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 53. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 54. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 55. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 56. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 57. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 58. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 59. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 60. UNITED STATES PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 61. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 62. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 63. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 64. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 65. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 66. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 67. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 68. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 69. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 70. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 71. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 72. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 73. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 74. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 75. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 76. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 77. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 78. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 79. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 80. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 81. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 82. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 83. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 84. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 85. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 86. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 87. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 88. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 89. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 90. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 91. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 92. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 93. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 94. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 95. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 96. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 97. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 98. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 99. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 100. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 101. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 102. GLOBAL PEPTIDE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 103. GLOBAL PEPTIDE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 104. GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL PEPTIDE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 214. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 220. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 223. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 226. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 229. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 232. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. ISRAEL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 238. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 241. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 244. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 247. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 253. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. NIGERIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 259. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. NORWAY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 265. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. POLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. GLOBAL PEPTIDE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 328. GLOBAL PEPTIDE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 329. GLOBAL PEPTIDE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 330. GLOBAL PEPTIDE THERAPEUTICS MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 331. GLOBAL PEPTIDE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 332. GLOBAL PEPTIDE THERAPEUTICS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 333. GLOBAL PEPTIDE THERAPEUTICS MARKET MERGER & ACQUISITION
  • TABLE 334. GLOBAL PEPTIDE THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 335. GLOBAL PEPTIDE THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 336. GLOBAL PEPTIDE THERAPEUTICS MARKET INVESTMENT & FUNDING
  • TABLE 337. GLOBAL PEPTIDE THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 338. GLOBAL PEPTIDE THERAPEUTICS MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!